Biotech - Spark Newswire

3 minute read

ADC Therapeutics Presents Updated Clinical Data At 2021 ASCO Meeting

June 4, 1:52 PM

ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, today announced updated

ADCT

3 minute read

FDA
News

Incyte, MorphoSys Announce 3-Year Results From Phase 2 L-MIND Study Of Tafasitamab In Combination With Lenalidomide For Treatment Of Relapsed Or Refractory DLBCL

By Benzinga Newsdesk

June 4, 1:45 PM

-- Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Incyte (NASDAQ:INCY) and MorphoSys US Inc., a fully owned subsidiary of MorphoSys AG ((FSE:

INCY

1 minute read

Chimerix Shares Spike Higher; FDA Approves Co’s Tembexa To Treat Smallpox

By Benzinga Newsdesk

June 4, 1:33 PM

https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-drug-treat-smallpox

CMRX

3 minute read

Merus Presents Clinical Data On Zenocutuzumab In NRG1-fusion (NRG1+) Cancers At 2021 ASCO Meeting

By Benzinga Newsdesk

June 4, 12:00 PM

Merus N.V. (NASDAQ:MRUS) ("Merus", "the Company", "we", or "our"), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and

MRUS

1 minute read

Amgen’s Stomach Cancer Drug Acquired in Five Prime Buyout Extends Patients’ Lives, Mid-Stage Study Shows

By Vandana Singh

June 4, 10:39 AM

Amgen Inc (NASDAQ:AMGN) has announced updated results for investigational bemarituzumab combined with chemotherapy from the Phase 2 FIGHT trial in patients…

AMGN

1 minute read

Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise

By Vandana Singh

June 4, 10:27 AM

Cyclerion Therapeutics Inc (NASDAQ:CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ:AKBA) for the development and commercialization of…

AKBA

1 minute read

FDA Expands EUA for Lower Dose Subcutaneous Version of Regeneron’s COVID-19 Antibody Cocktail

By Vandana Singh

June 4, 10:23 AM

The FDA has authorized a new, lower-dose version of Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) COVID-19 monoclonal antibody cocktail for those with COVID-19 who…

REGN

1 minute read

Surface Oncology’s SRF388 Shows Promising Anticancer Activity in Pretreated Patients

By Vandana Singh

June 4, 10:17 AM

Surface Oncology (NASDAQ:SURF) has announced new data from the ongoing Phase 1 studies of SRF388 and SRF617. SRF388 data will be…

SURF

1 minute read

4D pharma To Stop Testing Asthma Med in COVID-19 Patients

By Vandana Singh

June 4, 10:14 AM

4D pharma plc (NASDAQ: LBPS) has completed its target enrollment of 30 patients for Part A of its Phase 1/2 trial of MRx-4DP0004 in patients with partly controlled asthma.

LBPS